19.81
price down icon1.76%   -0.355
 
loading
Schlusskurs vom Vortag:
$20.16
Offen:
$20.09
24-Stunden-Volumen:
1.25M
Relative Volume:
0.36
Marktkapitalisierung:
$4.71B
Einnahmen:
$474.17M
Nettoeinkommen (Verlust:
$208.93M
KGV:
23.33
EPS:
0.8493
Netto-Cashflow:
$65.61M
1W Leistung:
+3.28%
1M Leistung:
+28.89%
6M Leistung:
-0.65%
1J Leistung:
+2.56%
1-Tages-Spanne:
Value
$19.63
$20.10
1-Wochen-Bereich:
Value
$18.73
$20.22
52-Wochen-Spanne:
Value
$13.76
$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Name
Firmenname
Adma Biologics Inc
Name
Telefon
(201) 478-5552
Name
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Name
Mitarbeiter
685
Name
Twitter
@AdmaBiologics
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
ADMA's Discussions on Twitter

Vergleichen Sie ADMA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ADMA
Adma Biologics Inc
19.81 4.79B 474.17M 208.93M 65.61M 0.8493
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.49 116.04B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
720.28 75.97B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.21 61.48B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
898.86 56.40B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
205.53 43.73B 447.02M -1.18B -906.14M -6.1812

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-07-19 Fortgesetzt Raymond James Strong Buy
2022-10-13 Eingeleitet Mizuho Buy
2021-11-11 Hochstufung Raymond James Outperform → Strong Buy
2021-11-09 Eingeleitet Cantor Fitzgerald Overweight
2019-06-04 Eingeleitet Jefferies Buy
2019-04-15 Bestätigt H.C. Wainwright Buy
2019-02-07 Fortgesetzt H.C. Wainwright Buy
2017-12-11 Bestätigt Maxim Group Buy
2017-11-14 Hochstufung Raymond James Mkt Perform → Outperform
2017-01-23 Hochstufung Maxim Group Hold → Buy
2016-08-01 Herabstufung Maxim Group Buy → Hold
2016-07-25 Bestätigt Maxim Group Buy
2015-05-13 Bestätigt Maxim Group Buy
2014-12-08 Eingeleitet Oppenheimer Outperform
2014-12-01 Bestätigt Maxim Group Buy
Alle ansehen

Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten

pulisher
Dec 02, 2025

Technical Reactions to ADMA Trends in Macro Strategies - news.stocktradersdaily.com

Dec 02, 2025
pulisher
Dec 02, 2025

ADMA Biologics, Inc. (NASDAQ:ADMA) Looks Just Right With A 25% Price Jump - simplywall.st

Dec 02, 2025
pulisher
Dec 01, 2025

Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - sharewise.com

Dec 01, 2025
pulisher
Nov 30, 2025

Elo Mutual Pension Insurance Co Buys 25,267 Shares of ADMA Biologics Inc $ADMA - MarketBeat

Nov 30, 2025
pulisher
Nov 28, 2025

Published on: 2025-11-29 10:13:00 - moha.gov.vn

Nov 28, 2025
pulisher
Nov 28, 2025

What analysts say about ADMA Biologics Inc stockMarket Sentiment Report & No Fee. No Catch. Just Smart Investment Ideas - earlytimes.in

Nov 28, 2025
pulisher
Nov 28, 2025

Guidance Update: How ADMA Biologics Inc. stock valuations compare to rivals2025 AllTime Highs & Fast Gain Swing Alerts - moha.gov.vn

Nov 28, 2025
pulisher
Nov 27, 2025

ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance

Nov 27, 2025
pulisher
Nov 27, 2025

Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 60.24%: Read This Before Placing a Bet - Zacks Investment Research

Nov 27, 2025
pulisher
Nov 26, 2025

ADMA Biologics (ADMA): Assessing Valuation as Short Interest Declines and Market Sentiment Improves - Sahm

Nov 26, 2025
pulisher
Nov 26, 2025

Where Will Sharp Investments Limited Stock Be in YEAR5 Growth ForecastExit Strategy Tips & These Stocks Are Just Getting Started - earlytimes.in

Nov 26, 2025
pulisher
Nov 26, 2025

Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average - sharewise.com

Nov 26, 2025
pulisher
Nov 26, 2025

Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - sharewise.com

Nov 26, 2025
pulisher
Nov 25, 2025

Adma Biologics (ADMA) Upgraded to Buy: Here's What You Should Know - sharewise.com

Nov 25, 2025
pulisher
Nov 24, 2025

What's Driving the Market Sentiment Around ADMA Biologics Inc? - Benzinga

Nov 24, 2025
pulisher
Nov 24, 2025

High Growth Tech Stocks In The US For November 2025 - Yahoo Finance

Nov 24, 2025
pulisher
Nov 23, 2025

Arihant Foundations Housing Limited Testing Reversal Zone on Weekly ChartLong-Term Growth Stocks & Breakout Stock Alerts - earlytimes.in

Nov 23, 2025
pulisher
Nov 22, 2025

Adma Biologics (ADMA) CEO Grossman sells $336k in shares By Investing.com - Investing.com South Africa

Nov 22, 2025
pulisher
Nov 21, 2025

ADMA Biologics CEO Adam S Grossman Sells Shares - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

[Form 4] ADMA BIOLOGICS, INC. Insider Trading Activity - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Adma Biologics (ADMA) CEO Grossman sells $336k in shares - Investing.com

Nov 21, 2025
pulisher
Nov 21, 2025

CEO Grossman Sells 21,000 ($336K) Of Adma Biologics Inc [ADMA] - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

Trading the Move, Not the Narrative: (ADMA) Edition - news.stocktradersdaily.com

Nov 21, 2025
pulisher
Nov 20, 2025

ADMA Biologics: Why The Dip To $16 Resets The Buy Case (NASDAQ:ADMA) - Seeking Alpha

Nov 20, 2025
pulisher
Nov 20, 2025

Why ADMA Biologics Inc. stock appeals to analysts2025 Price Targets & Risk Controlled Daily Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Building trade automation scripts for ADMA Biologics Inc.Earnings Growth Summary & Daily Technical Forecast Reports - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

ADMA Biologics Inc (ADMA) Stock forecasts - Yahoo Finance UK

Nov 17, 2025
pulisher
Nov 17, 2025

ADMA Biologics (ADMA) Is Up 7.2% After Raised Guidance and Share Buybacks Has the Bull Case Changed? - Sahm

Nov 17, 2025
pulisher
Nov 16, 2025

Will ADMA Biologics Inc. stock continue dividend increases2025 Trading Volume Trends & Stock Timing and Entry Methods - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Can ADMA Biologics Inc. stock attract ESG capital inflows2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Applying Wyckoff theory to ADMA Biologics Inc. stock2025 Performance Recap & Stepwise Trade Execution Plans - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - sharewise.com

Nov 15, 2025
pulisher
Nov 13, 2025

Risk adjusted return profile for ADMA Biologics Inc. analyzedJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

ADMA Biologics, Inc. (ADMA) Stock Price Quote Today & Current Price Chart - Capital.com

Nov 13, 2025
pulisher
Nov 13, 2025

Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com

Nov 13, 2025
pulisher
Nov 13, 2025

Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for Investors - sharewise.com

Nov 13, 2025
pulisher
Nov 12, 2025

Why ADMA Biologics' (NASDAQ:ADMA) Earnings Are Weaker Than They Seem - Yahoo Finance

Nov 12, 2025
pulisher
Nov 12, 2025

Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to Trade - sharewise.com

Nov 12, 2025
pulisher
Nov 10, 2025

(ADMA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com

Nov 10, 2025
pulisher
Nov 10, 2025

Adma Biologics Shares Maintain Upward Momentum on Strong Financial Performance - AD HOC NEWS

Nov 10, 2025

Finanzdaten der Adma Biologics Inc-Aktie (ADMA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Adma Biologics Inc-Aktie (ADMA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Grossman Adam S
President and CEO
Nov 19 '25
Sale
16.00
21,000
336,000
2,013,850
Grossman Adam S
President and CEO
Oct 24 '25
Option Exercise
5.40
15,000
81,000
2,040,850
Grossman Adam S
President and CEO
Oct 24 '25
Sale
16.00
21,000
336,000
2,019,850
$39.48
price up icon 0.82%
$31.70
price down icon 1.03%
$102.94
price up icon 2.50%
$96.03
price up icon 0.03%
biotechnology ONC
$313.97
price down icon 5.22%
$205.42
price up icon 0.11%
Kapitalisierung:     |  Volumen (24h):